AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
June 06, 2023 01:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Ariz., June 06, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer,...
AccuStem Announce Strategic Clinical and Operational Partnership
May 31, 2023 07:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, May 31, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, today...
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
May 02, 2023 07:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced...
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
December 06, 2022 07:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Dec. 06, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that its...
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
November 22, 2022 07:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Nov. 22, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced...
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors
November 16, 2022 07:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced...
AccuStem Announces Adjournment of Annual Meeting of Stockholders
October 10, 2022 16:15 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Oct. 10, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced...
AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer
September 13, 2022 09:00 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer,...
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
June 09, 2022 13:38 ET
|
AccuStem Sciences, Inc.
LONDON and PHOENIX, Ariz., June 09, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that...